According to a report, "Stem Cells Market Analysis By Product (Adult Stem Cells, hESC, Induced Pluripotent Stem Cells), By Application (Regenerative Medicine, Drug Discovery), By Technology, By Therapy, And Segment Forecasts, 2018 - 2025" , published by Grand View Research, Inc., The global stem cell market is expected to reach USD 15.63billion by 2025, growing at a CAGR of 9.2%, Extensive research carried out in Singapore and Japan is anticipated to drive progress with lucrative avenues. Scientists are engaged in discovering novel methods to create human stem cells. This is to address the increasing demand for stem cell production for potential investigation in disease management.
Key Takeaways from the report:
-
Adult stem cells dominated the market and is expected to maintain its dominance. This can be attributed to the several factors such as lower rejection rates, long term renewal property, and no ethical concerns associated with their usage
-
Application wise regenerative medicine is estimated to hold the substantial share of the revenue
-
Presence of significant number pipeline projects for regenerative medicine is expected to fuel growth in the market
-
In addition, exploding research projects have driven the need of harvesting techniques, thereby propelling progress of acquisition technology
-
Increased R&D activities and huge funds granted by funding bodies to advance cellular research in the U.S. have resulted into the large share of North America
-
Extensive research carried out in Singapore and Japan is anticipated to drive progress with lucrative avenues
-
Advanced Cell Technology Inc, Osiris Therapeutics Inc, Celgene Corporation, BIOTIME, INC., Cynata, and STEMCELL Technologies Inc., are some of the major companies operating in this market
-
A number of companies are engaged in seeking investment from overseas organizations and also developing partnerships with the pharmaceutical organizations
Scientists are engaged in discovering novel methods to create human stem cells. This is to address the increasing demand for stem cell production for potential investigation in disease management. This factor is certainly expected to accelerate the development of regenerative medicine, thus driving industrial growth.
UK stem cells market share, by technology, 2014 - 2025 (USD Million)
Browse More Reports in Biotechnology Industry:
Carcinoembryonic Antigen (CEA) Market: Constant technological advancements pertaining to the development of novel biomarkers which can be used in combination with other biomarkers is expected to boost usage rates over the forecast period. Furthermore, the increasing prevalence of cancer is expected to heighten the demand for effective diagnostic tools. According to the WHO estimates in 2012, global cancer incidences were nearly 14.1 million, which include 6.7 million female patients and 7.4 million male patients.
Bioinformatics Market: Growing clinical development of biopharmaceutical and increasing need for three dimensional drug designing technology are expected to drive the market growth over the next five years. Further development of bioinformatics tools, platforms and analysis platforms coupled with the introduction of novel technologies are expected to be high impact rendering factors for the growth of this market.
Global stem cell market, by region, 2016 (%)
Moreover, cellular therapies are recognized as the next major advancements in transforming healthcare. Firms are expanding their cellular therapy portfolio, understanding the future potential of this arena in the treatment of Parkinson's disease, type 1 diabetes, spinal cord injury, Alzheimer's disease, and others.
In March 2016, Scientists at Michigan State University unveiled new kind of cells “induced XEN cells” from a cellular trash pile. This discovery is expected to drive advancements in regenerative medicine. Such discoveries are anticipated to bolster research and sales in this market over the forecast period.
Grand View Research has segmented the global stem cells market on the basis of product, application, technology, therapy, and region:
Stem Cell Product Outlook (Revenue, USD Billion, 2014 - 2025)
-
Adult Stem Cells
-
Neuronal Stem Cells
-
Hematopoietic Stem Cells
-
Mesenchymal Stem Cells
-
Umbilical Cord Stem Cells
-
Others
-
-
Human Embryonic Stem Cells
-
Induced Pluripotent Stem Cells
-
Very Small Embryonic Like Stem Cells
Stem Cell Application Outlook (Revenue, USD Billion, 2014 - 2025)
-
Regenerative Medicine
-
Neurology
-
Orthopedics
-
Oncology
-
Hematology
-
Cardiovascular and Myocardial Infraction
-
Injuries
-
Diabetes
-
Liver Disorder
-
Incontinence
-
Others
-
-
Drug Discovery and Development
Stem Cell Technology Outlook (Revenue, USD Billion, 2014 - 2025)
-
Cell Acquisition
-
Bone Marrow Harvest
-
Umbilical Blood Cord
-
Apheresis
-
-
Cell Production
-
Therapeutic Cloning
-
In-vitro Fertilization
-
Cell Culture
-
Isolation
-
-
Cryopreservation
-
Expansion and Sub-Culture
Stem Cell Therapy Outlook (Revenue, USD Billion, 2014 - 2025)
-
Autologous Stem Cell Therapy
-
Allogeneic Stem Cell Therapy
Stem Cell Regional Outlook (Revenue, USD Billion, 2014 - 2025)
-
North America
-
U.S.
-
Canada
-
-
Europe
-
Germany
-
UK
-
-
Asia Pacific
-
China
-
Japan
-
-
Latin America
-
Brazil
-
-
Middle East & Africa
-
South Africa
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
For more information: www.grandviewresearch.com
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist - U.S.A.
Email:Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: Switzerland
Website: www.grandviewresearch.com/industry-analysis/stem-cells-market
